Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
Gray Announces Two General Manager Retirements
-
FOREWARN Partners with Bluegrass REALTORS®
-
GraniteShares launches new ETF on SMCI (Super Micro Computer) GraniteShares 2x Long SMCI Daily ETF (SMCL)
-
Sunrise Realty Trust Commits $32.0 Million in a Senior Loan for The Loren at Lady Bird Lake in Austin, Texas
-
Southern Realty Trust Originates $57.0 Million Senior Loan for The Loren at Lady Bird Lake in Austin, Texas
-
Advanced Flower Capital Inc. Announces Dividend for the Fourth Quarter 2024
-
Harvia completed repurchase of own shares
-
Notice about the statement of claim
-
Aligos Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
Change to Pacific Green's Accounting Policy
-
International Communication Forum: Pathways To A Sustainable Future
-
Ucore Rare Metals: US DoD Approves US$1.8 Million Payment
-
OPRAH WINFREY, CAITLIN CLARK, GOV. HEALEY, AND MORE INSPIRE AT MASSACHUSETTS CONFERENCE FOR WOMEN
-
BrightPath Bio and Cellistic Announces Process Development and Manufacturing Collaboration for Phase 1 Clinical Trial of iPSC-derived BCMA CAR-iNKT cell
-
Millionero Just Introduced Its Affiliate Program—Here’s Why It’s a Big Deal
-
BriaCell 2024 SABCS® Poster Highlights Ability of Bria-IMT™ Regimen to Increase Cancer-Fighting Immune Cells in Metastatic Breast Cancer
-
Sachem Capital Corp. Announces Chief Financial Officer Transition
-
Appointment of Non-Executive Director
-
Flowing of One Dharma, Harmonizing the World
-
LILT Receives Award to Address Intelligence and Foreign Language Challenges
-
Soluna Completes Final Conversion and Payoff of Convertible Notes
-
Did You Know Christmas Is Just the Beginning?
-
Alliance Witan PLC - Net Asset Value
-
Northwest Healthcare Properties Real Estate Investment Trust Announces December 2024 Distribution
-
Experts From Europe and U.S. Exchange Insights and Strategies to Reduce Crashes, Save Lives and Reduce Injury
-
Myriad Uranium Closes Over-Subscribed Private Placement
-
Tenet Welcomes First Elite Times CPA SME Clients to Business Hub
-
iSpecimen Reports Positive Results on Next Day Quote Program for Researchers and Providers
-
Applied Materials Announces Cash Dividend
-
FMC Corporation Declares Quarterly Dividend
-
Zimmer Biomet Receives FDA Clearance for OsseoFit™ Stemless Shoulder System for Total Shoulder Replacement
-
InspireSemi Announces Delisting Date as Part of Previously Announced Plan to Go Private
-
Safehold Declares Fourth Quarter 2024 Common Stock Dividend
-
VR Resources is Underway on Hole 4 at Empire with an 800m Step-out from Hole 2 on the Opposing Margin of the Westwood Intrusive Complex
-
MEFA’s U.Fund Gift of College Gift Card is a Perfect Gift Idea
-
Dentsply Sirona Declares Quarterly Cash Dividend
-
On National Salesperson Day, ValueSelling Associates and Selling Power Unveil a New B2B Sales Resource: Exploring How AI is Shaping the Future of Sales
-
Incyclix Bio Announces Interim Clinical Data from the Phase 1/2 Clinical Trial of INX-315 in Patients with CDK4/6 Inhibitor Resistant ER+/HER2- Breast Cancer or CCNE1-Amplified Solid Tumors
-
At EuroEcho, Ebit (Esaote Group) presents the world premiere of ZEfiRO, the new “cloud-native” PACS for the SUITESTENSA platform, redefining its design philosophy
-
AGF Management Limited Declares Fourth Quarter 2024 Dividend
-
Acoramidis Receives Positive CHMP Opinion for Treatment of Transthyretin Amyloid Cardiomyopathy (ATTR-CM)
-
Keywords to understand China: The 3rd plenum
-
Lucid Motors Stock Jumps as US EV Tax Credit Rumors Emerge
-
An Analysis of the Tech Bosses That Poured Money into the Recent US Elections
-
Continuum Green Energy is Set for its $430m IPO in India
-
Indusface Sets a New Standard with Industry-First 72-Hour API Compliance Capability on SwyftComply
-
Farmland Partners Declares $1.15 per Share Special Dividend After Strong Year
-
Exodus Movement, Inc. Announces Uplist to NYSE American Exchange
-
Chase Doors introduces the ColdGuard GEN II Sliding Door
-
Merck Receives Positive EU CHMP Opinion for WELIREG® (belzutifan) as Treatment for Adult Patients With Certain Types of Von Hippel-Lindau Disease-Associated Tumors and for Certain Previously Treated
